These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2049250)

  • 21. Application of a three-compartment model to a study of the effects of sex, alcohol dose and concentration, exercise and food consumption on the pharmacokinetics of ethanol in healthy volunteers.
    Wedel M; Pieters JE; Pikaar NA; Ockhuizen T
    Alcohol Alcohol; 1991; 26(3):329-36. PubMed ID: 1930365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic optimisation in the treatment of Parkinson's disease.
    Contin M; Riva R; Albani F; Baruzzi A
    Clin Pharmacokinet; 1996 Jun; 30(6):463-81. PubMed ID: 8792058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic-pharmacodynamic relationship of levodopa with and without tolcapone in patients with Parkinson's disease.
    Baas H; Zehrden F; Selzer R; Kohnen R; Loetsch J; Harder S
    Clin Pharmacokinet; 2001; 40(5):383-93. PubMed ID: 11432539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of dietary factors on levodopa pharmacokinetics.
    Fernandez N; Garcia JJ; Diez MJ; Sahagun AM; Díez R; Sierra M
    Expert Opin Drug Metab Toxicol; 2010 May; 6(5):633-42. PubMed ID: 20384552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A balanced carbohydrate: protein diet in the management of Parkinson's disease.
    Berry EM; Growdon JH; Wurtman JJ; Caballero B; Wurtman RJ
    Neurology; 1991 Aug; 41(8):1295-7. PubMed ID: 1866021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy volunteers.
    Crevoisier C; Monreal A; Metzger B; Nilsen T
    Eur Neurol; 2003; 49(1):39-44. PubMed ID: 12464717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.
    Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G
    Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of fat supplementation on glycaemic response and gastric emptying in adolescents with Type 1 diabetes.
    Lodefalk M; Aman J; Bang P
    Diabet Med; 2008 Sep; 25(9):1030-5. PubMed ID: 19183308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of levodopa/carbidopa delivered from gastric-retentive extended-release formulations in patients with Parkinson's disease.
    Chen C; Cowles VE; Sweeney M; Stolyarov ID; Illarioshkin SN
    J Clin Pharmacol; 2012 Jul; 52(7):1069-77. PubMed ID: 21610205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of ageing on the pharmacokinetics of levodopa in elderly patients with Parkinson's disease.
    Nagayama H; Ueda M; Kumagai T; Tsukamoto K; Nishiyama Y; Nishimura S; Hamamoto M; Katayama Y
    Parkinsonism Relat Disord; 2011 Mar; 17(3):150-2. PubMed ID: 21172738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient.
    Evans MA; Broe GA; Triggs EJ; Cheung M; Creasey H; Paull PD
    Neurology; 1981 Oct; 31(10):1288-94. PubMed ID: 7202139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of gastroretentive delivery of levodopa/carbidopa in patients with Parkinson disease.
    Chen C; Cowles VE; Sweeney M; Stolyarov ID; Illarioshkin SN
    Clin Neuropharmacol; 2012; 35(2):67-72. PubMed ID: 22377973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease.
    Fariello RG
    Drugs; 1998; 55 Suppl 1():10-6. PubMed ID: 9483165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paracetamol as a Post Prandial Marker for Gastric Emptying, A Food-Drug Interaction on Absorption.
    Bartholomé R; Salden B; Vrolijk MF; Troost FJ; Masclee A; Bast A; Haenen GR
    PLoS One; 2015; 10(9):e0136618. PubMed ID: 26352940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of gastric emptying in severe, burn-injured patients.
    Hu OY; Ho ST; Wang JJ; Ho W; Wang HJ; Lin CY
    Crit Care Med; 1993 Apr; 21(4):527-31. PubMed ID: 8472572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
    Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
    BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Levodopa loading test as an early marker of Parkinson's disease].
    Hatori K; Kondo T; Mizuno Y
    Nihon Rinsho; 1997 Jan; 55(1):207-12. PubMed ID: 9014451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Optimisation of treatment of Parkinson's disease with levodopa].
    Białecka M; Adamiak U; Gawrońska-Szklarz B
    Neurol Neurochir Pol; 2009; 43(5):446-59. PubMed ID: 20054747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson's disease.
    Lipp MM; Batycky R; Moore J; Leinonen M; Freed MI
    Sci Transl Med; 2016 Oct; 8(360):360ra136. PubMed ID: 27733560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.